Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Screening

Correlation of genotype and phenotype in paraganglioma

Screening of patients with paraganglioma revealed a high prevalence of germ line mutations in genes encoding subunits of the succinate dehydrogenase complex, according to a new study. Should gene testing become a routine part of the clinical management of patients with paraganglioma?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Burnichon, N. et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J. Clin. Endocrinol. Metab. 94, 2817–2827 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848–851 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. Neumann, H. P. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Eng. J. Med. 46, 1459–1466 (2002).

    Article  Google Scholar 

  4. Amar, L. et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23, 8812–8818 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Baysal, B. E. et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J. Med. Genet. 39, 178–183 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mannelli, M. et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J. Clin. Endocrinol. Metab. 94, 1541–1547 (2009).

    Article  CAS  PubMed  Google Scholar 

  7. Neumann, H. P. et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res. 69, 3650–3656 (2009).

    Article  CAS  PubMed  Google Scholar 

  8. Hao, H. X. et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325, 1139–1142 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Timmers, H. J. et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J. Clin. Oncol. 25, 2262–2269 (2007).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baysal, B. Correlation of genotype and phenotype in paraganglioma. Nat Rev Endocrinol 5, 594–595 (2009). https://doi.org/10.1038/nrendo.2009.202

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.202

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing